1 Introduction
1.1 What Is This Report About?
1.2 Hormonal Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hormonal Disorders Market, United States
2.1 Hormonal Disorders Market, United States, Revenue ($m), 2024-2036
2.1.1 Thyroid Function Tests Market, United States, Revenue ($m), by Segment, 2024-2036
2.2 Hormonal Disorders Market, United States, Volume (Units), 2024-2036
2.2.1 Thyroid Function Tests Market, United States, Volume (Units), by Segment, 2024-2036
2.3 Hormonal Disorders Market, United States, Average Price ($), 2024-2036
2.4 Hormonal Disorders Market, United States, Company Share by Revenue ($m), 2025
3 Hormonal Disorders Market Pipeline Products
3.1 Hormonal Disorders Market Pipeline Products
3.2 Hormonal Disorders - Pipeline Products by Stage of Development
3.3 Hormonal Disorders - Pipeline Products by Segment
3.4 Hormonal Disorders - Pipeline Products by Territory
3.5 Hormonal Disorders - Pipeline Products by Regulatory Path
3.6 Hormonal Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in United States, Hormonal Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Beckman Coulter Inc
4.2.1 Company Overview
4.3 Roche Diagnostics International Ltd
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
4.5.1 Company Overview
4.6 Inova Diagnostics Inc
4.6.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 17, 2025: Fortrea Appoints Agnieszka Gallagher as General Counsel
5.1.2 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
5.1.3 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
5.1.4 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
5.1.5 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
5.1.6 Oct 09, 2025: Abbott And Abbott Fund Support Northern Illinois Food Bank With $250,000 Grant To Address Childhood Hunger
5.2 Financial Announcements
5.2.1 Jan 05, 2026: Abbott Hosts Conference Call for Fourth-Quarter Earnings
5.3 Government and Public Interest
5.3.1 Nov 25, 2025: Fortrea to Present at Citi and Evercore Healthcare Conferences
5.4 Other Significant Developments
5.4.1 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
5.5 Product News
5.5.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
5.5.2 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers
5.5.3 Jul 16, 2025: Multicenter Trial Confirms Near-Infrared Autofluorescence Increases Detection of Parathyroid Glands
5.6 Strategy And Business Planning
5.6.1 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group
5.6.2 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
5.6.3 Oct 29, 2025: EazeBio And UC Santa Cruz Form Strategic Partnership For Instrument-Free Diagnostics
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 3: Hormonal Disorders Market, United States, Volume (Units), 2024-2036
Table 4: Thyroid Function Tests Market, United States, Volume (Units), 2024-2036
Table 5: Hormonal Disorders Market, United States, Average Price ($), 2024-2036
Table 6: Hormonal Disorders Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Hormonal Disorders Market Pipeline Products
Table 8: Hormonal Disorders - Pipeline Products by Stage of Development
Table 9: Hormonal Disorders Companies - Pipeline Products by Stage of Development
Table 10: Hormonal Disorders - Pipeline Products by Segment
Table 11: Hormonal Disorders - Pipeline Products by Territory
Table 12: Hormonal Disorders - Pipeline Products by Regulatory Path
Table 13: Hormonal Disorders - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hormonal Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 2: Thyroid Function Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hormonal Disorders Market, United States, Volume (Units), 2024-2036
Figure 4: Thyroid Function Tests Market, United States, Volume (Units), 2024-2036
Figure 5: Hormonal Disorders Market, United States, Company Share (%), 2025
Figure 6: Hormonal Disorders - Pipeline Products by Stage of Development
Figure 7: Hormonal Disorders - Pipeline Products by Segment
Figure 8: Hormonal Disorders - Pipeline Products by Territory
Figure 9: Hormonal Disorders - Pipeline Products by Regulatory Path
Figure 10: Hormonal Disorders - Pipeline Products by Estimated Approval Date
